Coronavirus information - what we are doing at NDORMS to support our staff and students and the community
20 March 2020
NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.
9 March 2020
Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.
31 January 2020
Dr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
20 January 2020
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
15 January 2020
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.
6 December 2019
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
12 November 2019
Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.
23 October 2019
A careers event held by NDORMS offered information and advice to postdoctoral researchers transitioning to becoming independent group leaders.
17 September 2019
When immune cells detect harmful pathogens or cancer, they mobilise and coordinate a competent defence response. To do this effectively immune cells must communicate in a way that is tailored to the pathogenic insult. Consequently, the body's response to various health challenges depends on successful coordination among the cells of the immune system.
30 August 2019
Researchers at the Kennedy Institute identify a molecular pathway to boost vaccine responses in the elderly.
21 August 2019
Oxford is the newest partner of the national Research into Inflammatory Arthritis Centre Versus Arthritis (RACE) which has been awarded continued funding of nearly £2m over the next five years from Versus Arthritis.
15 July 2019
A new study from the Kennedy Institute of Rheumatology reveals a role for blood vessels in promoting therapy resistance of cancer metastasis in bone.
8 July 2019
The Kennedy Institute recently hosted a visit from the National Rheumatoid Arthritis Society (NRAS) to explore opportunities to partner on patient involvement approaches in arthritis research.
2 July 2019
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
5 June 2019
Congratulations to Kennedy researchers Professor Chris Buckley, Professor Mark Coles and Dr Stephen Sansom who have been awarded £1.5M funding from the Medical Research Council (MRC) to explore fibroblasts as an emerging target to treat chronic inflammatory disease.
30 May 2019
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
28 May 2019
New research at the Kennedy Institute reveals potential of a novel class of drugs for the treatment of rheumatoid arthritis.